Back to Network
3
Shared Docs
3
Same-Page
3 / 3
Mentions
Document Mentions (3 shared documents)
2 mentions1 same-page
Page ?Same page
proves Remdesivir As Cases Spike. • Azar Dismisses Report Of Tensions With Hahn. • Azar: New CDC Guidelines On Close Contact A "Call To Action." • FDA Advisory Committee Debates Safety, Efficacy Standards For Vaccine. • Palantir System To Help Track Manufacture, Distribution Of COVID Vaccines. • Consensus Emerges COVID Rarely Tran
Efficacy Standards For Vaccine. The Washington Post (10/22, McGinley, Johnson, 14.2M) reports that vaccine experts on Thursday "rigorously debated the Food and Drug Administration's planned standards for clearing a coronavirus vaccine quickly for broad use, discussing what level of evidence would be sufficient to establish safe
2 mentions1 same-page
Page ?Same page
proves Remdesivir As Cases Spike. • Azar Dismisses Report Of Tensions With Hahn. • Azar: New CDC Guidelines On Close Contact A "Call To Action." • FDA Advisory Committee Debates Safety, Efficacy Standards For Vaccine. • Palantir System To Help Track Manufacture, Distribution Of COVID Vaccines. • Consensus Emerges COVID Rarely Tran
0/22/covid-vaccine-safety-effectiveness- guidelines/> (10/22, McGinley, Johnson, 14.2M) reports that vaccine experts on Thursday "rigorously debated the Food and Drug Administration's planned standards for clearing a coronavirus vaccine quickly for broad use, discussing what level of evidence would be sufficient to establish safet
2 mentions1 same-page
Page ?Same page
proves Remdesivir As Cases Spike. • Azar Dismisses Report Of Tensions With Hahn. • Azar: New CDC Guidelines On Close Contact A "Call To Action." • FDA Advisory Committee Debates Safety, Efficacy Standards For Vaccine. • Palantir System To Help Track Manufacture, Distribution Of COVID Vaccines. • Consensus Emerges COVID Rarely Tran
Efficacy Standards For Vaccine. The Washington Post (10/22, McGinley, Johnson, 14.2M) reports that vaccine experts on Thursday "rigorously debated the Food and Drug Administration's planned standards for clearing a coronavirus vaccine quickly for broad use, discussing what level of evidence would be sufficient to establish safe
Sponsored
Mutual Connections (732)
Entities connected to both FDA Advisory Committee Debates Safety and the Food and Drug Administration's
Barack Obama
PERSON3 w/ FDA·10 w/ the
LB
Leon Black
PERSON3 w/ FDA·10 w/ the
Julie K. Brown
PERSON3 w/ FDA·10 w/ the
Donald Trump
PERSON3 w/ FDA·10 w/ the
Vladimir Putin
PERSON3 w/ FDA·10 w/ the
HA
Haberman
PERSON3 w/ FDA·9 w/ the
Scarborough
PERSON3 w/ FDA·9 w/ the
comScore
ORGANIZATION3 w/ FDA·9 w/ the
Bulletin Intelligence
ORGANIZATION3 w/ FDA·9 w/ the
USA Today
ORGANIZATION3 w/ FDA·9 w/ the
Milwaukee
LOCATION3 w/ FDA·9 w/ the
The New York Post
ORGANIZATION3 w/ FDA·9 w/ the
The Chicago Sun-Times
ORGANIZATION3 w/ FDA·9 w/ the
India
LOCATION3 w/ FDA·9 w/ the
Chris Tucker
PERSON3 w/ FDA·9 w/ the
FBI
ORGANIZATION3 w/ FDA·9 w/ the
Hunter Biden
PERSON3 w/ FDA·9 w/ the
Seattle
LOCATION3 w/ FDA·9 w/ the
Mark Meadows
PERSON3 w/ FDA·9 w/ the
Mike Pence
PERSON3 w/ FDA·9 w/ the